The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
- PMID: 12923801
- DOI: 10.1002/pon.742
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
Abstract
Purpose: The primary purpose of this study was to compare the neuropsychological performance of long-term survivors of breast cancer and lymphoma treated with standard dose chemotherapy who carried the epsilon 4 allele of the Apolipoprotein E (APOE) gene to those who carry other APOE alleles.
Patients and methods: Long-term survivors (mean=8.8+/-4.3 years post-treatment) of breast cancer (N=51, age=55.9+/-8.8) or lymphoma (N=29, age=55.8+/-11.6) who had been treated with standard-dose chemotherapy completed a standardized battery of neuropsychological and psychological tests. Survivors were also classified into two groups based on the presence (N=17) or absence (N=63) of at least one epsilon 4 allele of APOE.
Results: Analysis of covariance, controlling for age, gender, education, diagnosis, and WRAT-3 reading subtest (a proxy measure of baseline IQ), indicated that survivors with at least one epsilon 4 allele scored significantly lower in the visual memory (p<0.03) and the spatial ability (p<0.05) domains and tended to score lower in the psychomotor functioning (p<0.08) domain as compared to survivors who did not carry an epsilon 4 allele. No group differences were found on depression, anxiety, or fatigue.
Conclusions: The results of this study provide preliminary support for the hypothesis that the epsilon 4 allele of APOE may be a potential genetic marker for increased vulnerability to chemotherapy-induced cognitive decline.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
-
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.J Clin Oncol. 2002 Jan 15;20(2):485-93. doi: 10.1200/JCO.2002.20.2.485. J Clin Oncol. 2002. PMID: 11786578
-
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21. Patient Educ Couns. 2007. PMID: 17320337
-
Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.Arch Gen Psychiatry. 2005 Feb;62(2):209-16. doi: 10.1001/archpsyc.62.2.209. Arch Gen Psychiatry. 2005. PMID: 15699298
-
Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.Oncol Nurs Forum. 2005 Mar 5;32(2):329-42. doi: 10.1188/05.ONF.329-342. Oncol Nurs Forum. 2005. PMID: 15759070 Review.
-
Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.Crit Rev Oncol Hematol. 2012 Jul;83(1):99-111. doi: 10.1016/j.critrevonc.2011.09.001. Epub 2011 Oct 19. Crit Rev Oncol Hematol. 2012. PMID: 22015329 Review.
Cited by
-
Reliable change in neuropsychological assessment of breast cancer survivors.Psychooncology. 2016 Jan;25(1):43-50. doi: 10.1002/pon.3799. Epub 2015 Mar 23. Psychooncology. 2016. PMID: 25808921 Free PMC article. Clinical Trial.
-
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Semin Oncol. 2013 Dec;40(6):709-25. doi: 10.1053/j.seminoncol.2013.09.006. Semin Oncol. 2013. PMID: 24331192 Free PMC article. Review.
-
Investigating the relationship between COMT polymorphisms and working memory performance among childhood brain tumor survivors.Pediatr Blood Cancer. 2014 Jan;61(1):40-5. doi: 10.1002/pbc.24649. Epub 2013 Aug 19. Pediatr Blood Cancer. 2014. PMID: 23956130 Free PMC article.
-
Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.Am J Geriatr Psychiatry. 2017 Dec;25(12):1415-1426. doi: 10.1016/j.jagp.2017.04.001. Epub 2017 Apr 6. Am J Geriatr Psychiatry. 2017. PMID: 28495470 Free PMC article. Review.
-
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy-Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors.Small. 2024 Oct;20(41):e2300744. doi: 10.1002/smll.202300744. Epub 2023 Apr 14. Small. 2024. PMID: 37058079 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous